Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	4.07	15.00	-14.41
Graham Fair Price	-63.85	6.91	19.13
PEG	891.02	-0.24	0.02
Price/Book	43.53	6.08	4.24
Price/Cash Flow	-1575.56	-386.33	-23.06
Prices/Earnings	574.11	27.11	-4.02
Price/Sales	7.14	5.54	5.17
Price/FCF	-1575.56	-386.33	-23.06
Naive Interpretation	member

01 - Valuation · Bad

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-18.64	0.38	0.47
Operating Margin	-37.06	0.14	-0.22
ROA	-84.74	< 0.005	< 0.005
ROE	-0.26	0.06	-78.71
ROIC	-0.05	0.04	-30.09
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.16	-0.13	21.73
Dividends QOQ	0.13	-0.11	-13.44
EBIT QOQ	-1.41	1.65	16.55
EPS QOQ	-1.68	1.14	-31.98
FCF QOQ	-2.26	0.93	-58.75
Revenue QOQ	-0.40	0.03	-93.11
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	-6878.36	-212.71	96.91
Days Sales Outstanding (DSO)	507.61	494.72	-2.54
Inventory Turnover	-0.01	-0.42	-3133.69
Debt/Capitalization	0.61	0.73	20.78
Quick Ratio	4.45	19.78	344.61
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	7.86	6.15	-21.67
Cash	31.48	236.11	649.96
Capex	-0.10	-0.19	-83.82
Free Cash Flow	-1.44	-0.10	93.29
Revenue	6.44	6.75	4.94
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	4.57	24.77	441.90
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.48	-10.04	5.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating